TNF and focal segmental glomerulosclerosis: While plasma from patients with post-transplant FSGS relapse activated β3 integrin to disrupt the podocyte cytoskeleton, this effect was inhibited by pre-incubation of the plasma with antibodies against TNF-α [21].